ETHERNA IMMUNOTHERAPIES

{
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-03-18",
    "filing_date": "2025-03-14",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), KAPITAAL, AANDELEN"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2025-02-27",
    "unanimous": true
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "full_restatement",
    "trigger": "capital_change_consequence",
    "language_after": "nl",
    "language_before": "nl"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full_after": "ETHERNA IMMUNOTHERAPIES",
    "legal_form_after": "Naamloze vennootschap",
    "name_full_before": "ETHERNA IMMUNOTHERAPIES",
    "current_zetel_raw": "Galileilaan 19 2845 Niel",
    "legal_form_before": "Naamloze vennootschap"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "The article was replaced with a new text detailing the increased capital of \u20AC1,979,105.59 represented by 1,478,585 shares across four classes.",
      "new_text": "-1. Geplaatst kapitaal\nHet geplaatst kapitaal bedraagt EEN MILJOEN NEGENHONDERDNEGENENZEVENTIGDUIZEND\nHONDERDENVIJF EURO NEGENENVIJFTIG CENT (\u20AC 1.979.105,59), vertegenwoordigd door EEN\nMILJOEN VIERHONDERDACHTENZEVENTIGDUIZEND VIJFHONDERDVIJFENTACHTIG",
      "change_kind": "replaced",
      "article_title": null,
      "article_number": "5-1."
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Lars HANSEN",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "afschrift van de akte",
    "lijst van warranten",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": null,
    "voorkeurrecht_rules_changed": true,
    "aandelenoverdracht_restrictions_changed": true
  },
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 1478585,
    "shares_before": 1478585,
    "capital_after_eur": 1979105.59,
    "capital_before_eur": 1979105.59,
    "share_classes_after": [
      {
        "count": 46536,
        "label": "Gewone Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      },
      {
        "count": 338981,
        "label": "Bevoorrechte Klasse A Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      },
      {
        "count": 575078,
        "label": "Bevoorrechte Klasse B1 Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      },
      {
        "count": 517990,
        "label": "Bevoorrechte Klasse B2 Aandelen",
        "rights_summary": "Same rights and benefits as existing Ordinary Shares",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1979656.33,
      "delta_eur": 550.74,
      "before_eur": 1979105.59,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "houder van Stock Optie Warrants",
          "share_class": "Gewone Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 411,
          "contribution_amount_eur": 550.74
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Gewone Aandelen",
        "n_new_shares": 411,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 550.74,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-03-18",
    "filing_date": "2025-03-14",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2025-02-27",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "afschrift van de akte",
    "lijst van warranten",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "houder van Stock Optie Warrants",
      "role": null,
      "n_shares": 1478585,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 46536,
      "class_name": "Gewone Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 338981,
      "class_name": "Bevoorrechte Klasse A Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 575078,
      "class_name": "Bevoorrechte Klasse B Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 517990,
      "class_name": "Bevoorrechte Klasse B2 Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "Naamloze vennootschap",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1979105.59,
      "delta_eur": 550.7399999999907,
      "before_eur": 1978554.85,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Didier Delanoye",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "voorzitter raad van bestuur",
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": "A02154",
        "name": "Didier Delanoye",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "PwC Bedrijfsrevisoren BV",
        "address": "1831 Diegem, Culliganlaan 5",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering van aandeelhouders beslist met eenparigheid van stemmen om PwC Bedrijfsrevisoren BV (B0009), met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, vertegenwoordigd door de Heer Didier Delanoye (A02154), te herbenoemen als commissaris van de vennootschap en dit voor een p",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "3"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts, en iedere advocaat of werknemer van Deloitte Legal, c/o Deloitte Legal, Gat",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "successor_conditional",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "de heer Antonin de Fougerolles wordt benoemd als nieuwe voorzitter van de raad van bestuur",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "mandate_confirmation",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "de benoeming van de heer Antonin de Fougerolles te bekrachtigen als voorzitter van de raad van bestuur van de Vennootschap, met ingang vanaf de datum van ondertekening van deze notulen",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Antonin de Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "het vergoedingspakket van de heer Antonin de Fougerolles voor zijn rol als voorzitter van de raad van bestuur, zoals hierboven voorgesteld en goedgekeurd door de raad van bestuur, te bekrachtigen",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-11-05",
    "filing_date": "2024-06-26",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-04-23",
      "unanimous": true
    },
    {
      "body": "algemene_vergadering",
      "date": "2024-06-26",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nicolas Bosschaerts",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzonder gevolmachtigde"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "stage": null,
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-25",
    "filing_date": "2024-06-21",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-06-17",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0502.703.389",
        "name": "ETHERNA IMMUNOTHERAPIES",
        "role": "other",
        "address": "Galileilaan 19, 2845 Niel",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:180",
      "7:187",
      "184 WIB"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 106363,
    "real_estate_included": false,
    "patrimony_description": "De besluiten betreffen de uitgifte van 106.363 Stock Optie Warrants en de verhogen van het kapitaal van de vennootschap op basis van de uitoefenprijs van deze opties. Het kapitaal wordt verhoogd indien de opties worden uitgeoefend, met een eventueel deel van het verschil tussen uitoefenprijs en fractiewaarde op een onbeschikbare rekening \u0027uitgiftepremie\u0027.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Deloitte Legal-Lawyers",
    "person_name": null,
    "org_rep_person_name": "Henri-Simon Vande Vyver, Filip Van Acoleyen, Nicolas Bosschaerts"
  },
  "summary_narrative": "De buitengewone algemene vergadering van ETHERNA IMMUNOTHERAPIES besliste de vernietiging van 49.536 vervallen Stock Optie Warrants en de uitgifte van 106.363 nieuwe Stock Optie Warrants volgens het Aandelenoptieplan 2024. Daarnaast werd het kapitaal van de vennootschap verhoogd op basis van de uitoefenprijzen van de uitgeoefende opties, met een specifieke boekhoudkundige behandeling van eventuele premies. De bestuurders kregen volmacht om de vereiste formaliteiten uit te voeren.",
  "co_filed_documents": [
    "volmachten",
    "aandelenoptieplan",
    "verslagen van de raad van bestuur",
    "verslagen van de commissaris",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "notary": {
    "name": "Lars HANSEN",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-25",
    "filing_date": "2024-06-21",
    "act_kind_objet": "STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), DIVERSEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-06-17",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "other"
    ],
    "scope": null,
    "trigger": null,
    "language_after": null,
    "language_before": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full_after": "ETHERNA IMMUNOTHERAPIES",
    "legal_form_after": "Naamloze vennootschap",
    "name_full_before": "ETHERNA IMMUNOTHERAPIES",
    "current_zetel_raw": "Galileilaan 19, 2845 Niel",
    "legal_form_before": "Naamloze vennootschap"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Henri-Simon Vande Vyver",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Filip Van Acoleyen",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Nicolas Bosschaerts",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "Deloitte Legal-Lawyers",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "Vaststelling van de uitgifte- en uitoefenvoorwaarden van de Stock Optie Warrants.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "7:180"
    },
    {
      "summary": "Wijziging van de rechten verbonden aan elke soort aandelen.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "7:155"
    },
    {
      "summary": "Regelgeving voor het op een afzonderlijke rekening onder het eigen vermogen op het passief van de balans vermelden van het bedrag.",
      "new_text": null,
      "change_kind": "amended",
      "article_title": null,
      "article_number": "184"
    }
  ],
  "governance_change": {
    "organ_kind_after": null,
    "organ_kind_before": null,
    "admin_delegated_added": [
      {
        "name": "Henri-Simon Vande Vyver",
        "excluded_powers": []
      },
      {
        "name": "Filip Van Acoleyen",
        "excluded_powers": []
      },
      {
        "name": "Nicolas Bosschaerts",
        "excluded_powers": []
      },
      {
        "name": "iedere andere advocaat of medewerker van Deloitte Legal-Lawyers",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": null,
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Lars HANSEN",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "afschrift van de akte",
    "volmachten",
    "aandelenoptieplan",
    "verslagen van de raad van bestuur",
    "verslagen van de commissaris",
    "geco\u00F6rdineerde tekst van de statuten en historiek van de statutenwijzigingen"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "eigen_aandelen_inkoop",
      "eigen_aandelen_vernietigen",
      "share_class_creation",
      "capital_increase_cash"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": null,
    "capital_before_eur": null,
    "share_classes_after": [
      {
        "count": null,
        "label": "nieuwe aandelen",
        "rights_summary": "De uitgifte van de nieuwe aandelen zal niet evenredig aan het aantal uitgegeven aandelen binnen elke soort gebeuren, hetgeen een wijziging van de rechten verbonden aan elke soort inhoudt.",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "CEO",
      "person": {
        "rrn": null,
        "name": "Bernard Sagaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "voorzitter raad van bestuur",
      "person": {
        "rrn": null,
        "name": "Russell Greig",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "voorzitter raad van bestuur",
      "person": {
        "rrn": null,
        "name": "Marijn Dekkers",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Inphacon BV",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-09-21",
      "evidence_quote": "De Raad heeft unaniem de benoeming van Inphacon BV, met Bernard Sagaert als vaste vertegenwoordiger, goedgekeurd voor de functie van CEO, met ingang van 21 september 2023, voor onbepaalde duurtijd.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Russell Greig",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Greig Biotechnology Global Consulting Inc.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-09-22",
      "evidence_quote": "Russell Greig, optredend in zijn hoedanigheid als vaste vertegenwoordiger van Greig Biotechnology Global Consulting Inc., heeft de Raad op de hoogte gesteld van zijn beslissing om af te treden als bestuurder en voorzitter van de Raad.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Russell Greig",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Greig Biotechnology Global Consulting Inc.",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": "2023-09-22",
      "evidence_quote": "De Raad heeft kennis genomen van het ontslag van Greig Biotechnology Global Consulting Inc., met Russell Greig als vaste vertegenwoordiger, als bestuurder en voorzitter van de Vennootschap, met ingang van 22 september 2023.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "voorzitter",
      "person": {
        "rrn": null,
        "name": "Marijn Dekkers",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Marijn Dekkers, als tweede oudste lid van de Raad, stemde ermee in om als voorzitter te fungeren, in afwachting van de definitieve benoeming van een nieuwe voorzitter door de aandeelhoudersvergadering overeenkomstig artikel 11 van de statuten.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Nicolas Bosschaerts",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Christoph Michiels",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Henri-Simon Vande Vyver",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Sofie Van Paesschen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers BV",
        "address": "Brussels National Airport 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De Raad heeft unaniem besloten om een bijzondere volmacht te verlenen aan iedere bestuurder van de Vennootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, mevrouw Sofie Van Paesschen, de heer Nicolas Bosschaerts en iedere advocaat of werknemer van Deloitte Legal - Lawyers BV",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-10",
    "filing_date": "2024-05-15",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "raad_van_bestuur",
      "date": "2023-09-21",
      "unanimous": true
    },
    {
      "body": "raad_van_bestuur",
      "date": "2023-09-22",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nicolas Bosschaerts",
    "org_rep_person_name": null,
    "person_role_at_subject": "bestuurder"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "21-23 NEWELL ROAD LLC",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Antonin Rollet De Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2022-12-21",
      "evidence_quote": "De voorzitter stelt vast dat, op basis van de stemmen uitgebracht per stembrief, zijnde alle uitgebrachte stemmen op deze bijzondere algemene vergadering, de volgende besluiten zijn genomen door de algemene vergadering van aandeelhouders: \u2022 Aanstelling van Antonin Rollet De Fougerolles als onafhanke",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Antonin Rollet De Fougerolles",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou en iedere advocaat of werknemer van Deloitte Legal, c/o Del",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Christoph Michiels",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Henri-Simon Vande Vyver",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Roan Asselman",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Nicolas Bosschaerts",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Anthea Debou",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal",
        "address": "Gateway Building, Luchthaven Brussel Nationaal 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou en iedere advocaat of werknemer van Deloitte Legal",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal",
        "address": "Gateway Building, Luchthaven Brussel Nationaal 1 J, 1930 Zaventem, Belgi\u00EB",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Venriootschap en aan de heer Christoph Michiels, de heer Henri-Simon Vande Vyver, de heer Roan Asselman, de heer Nicolas Bosschaerts, mevrouw Anthea Debou en iedere advocaat of werknemer van Deloitte Legal",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2023-03-20",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "bijzondere_algemene_vergadering",
      "date": "2022-12-21",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Anthea Debou",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bijzonder gevolmachtigde"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "Antonin Rollet De Fougerolles",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "CEO and person responsible for daily management",
      "person": {
        "rrn": null,
        "name": "The Truffaldino Partnership Limited",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "interim CEO and person responsible for daily management",
      "person": {
        "rrn": null,
        "name": "Inphacon BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "board member",
      "person": {
        "rrn": null,
        "name": "The Truffaldino Partnership Limited",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "board member",
      "person": {
        "rrn": null,
        "name": "Inphacon BV",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": true
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "naamloze vennootschap",
    "old": "naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "CHIEN Kenneth Randall",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DEKKERS Marinus Emmanuel",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "PARTICIPATIEMAATSCHAPPIJ VLAANDEREN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent OSSIPOW",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vianova SPRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris BUYSE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Yijun CHEN",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Biotech Fonds Vlaanderen",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 31885512.14,
      "delta_eur": 29906957.29,
      "before_eur": 1978554.85,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Alexandra Tolia",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Frank Kalkbrenner",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ni Xie",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris Buyse",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "Russeil Greig",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "John de Koning",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent Ossipow",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "onafhankelijke bestuurder",
      "person": {
        "rrn": null,
        "name": "Vincent Brichard",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Pieter-Jan Van Durme",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Didier Delanoye",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gewone bestuurder",
      "person": {
        "rrn": null,
        "name": "KALKBRENNER Frank Axel",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "eTheRNA Immunotherapies"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 12203770.09,
      "delta_eur": 11164320.0,
      "before_eur": 1039450.09,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "stage": null,
  "notary": {
    "name": "Marc SLEDSENS",
    "firm_city": null,
    "firm_name": "Deckers notarissen",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2020-08-11",
    "filing_date": "2020-08-07",
    "act_kind_objet": "KAPITAAL, AANDELEN, DIVERSEN"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2020-07-31",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0502.703.389",
        "name": "ETHERNA IMMUNOTHERAPIES",
        "role": "other",
        "address": "Galileilaan 19, 2845 Niel",
        "is_foreign": false,
        "legal_form": "Naamloze vennootschap",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "7:155",
      "7:180",
      "184 WIB"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 35311,
    "real_estate_included": false,
    "patrimony_description": "De kapitaalverhoging vindt plaats door inbreng in geld. Het geplaatste kapitaal wordt verhoogd van \u20AC992.185,81 naar \u20AC1.039.450,09. Daarnaast worden nieuwe Bevoorrechte Klasse B Aandelen, Additionele Klasse B Anti-dilutie Warrants en Stock Optie Warrants uitgegeven.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES",
    "legal_form": "Naamloze vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Marc SLEDSENS",
    "org_rep_person_name": null
  },
  "summary_narrative": "De buitengewone algemene vergadering van aandeelhouders van ETHERNA IMMUNOTHERAPIES besliste een kapitaalverhoging met \u20AC47.264,28 door de uitgifte van 35.311 Bevoorrechte Klasse B Aandelen in geld. Daarnaast werden 3 Additionele Klasse B Anti-dilutie Warrants en 58.361 Stock Optie Warrants uitgegeven. Het kapitaal werd verhoogd tot \u20AC1.039.450,09. De uitoefening van de opties is afhankelijk van de uitgifte van de opties en leidt tot verdere kapitaalverhoging. De commissaris werd vervangen door Pieter-Jan Van Durme.",
  "co_filed_documents": [
    "afschrift van de akte",
    "volmachten",
    "verslagen van de raad van bestuur en verslag van de commissaris, opgesteld in toepassing van de artikelen 7:155 en 7:180 van het WVV",
    "Bijlage 6.1 Additionele Klasse B Anti-dilutie Warrants",
    "Aandelenoptieplan 2020"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1039450.09,
      "delta_eur": 47264.27999999991,
      "before_eur": 992185.81,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris De Jonghe",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kenneth Wils",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "eTheRNA Immunotherapies"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Chris DE JONGHE",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "YIJUN Chen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "XIE Ni",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  },
  "legal_form_change": {
    "new": "Naamloze vennootschap",
    "old": "Naamloze vennootschap",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 26754470.57,
      "delta_eur": 25966961.0,
      "before_eur": 787509.57,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "ETHERNA IMMUNOTHERAPIES"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Deloitte Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0502.703.389",
    "name_full": "eTheRNA immunotherapies"
  }
}